Pharmacokinetic study of two different rifabutin doses co-administered with lopinavir/ritonavir in African HIV and tuberculosis co-infected adult patients

BACKGROUND: This study aimed to assess the pharmacokinetic profile of 150 mg rifabutin (RBT) taken every other day (every 48 h) versus 300 mg RBT taken every other day (E.O.D), both in combination with lopinavir/ritonavir (LPV/r), in adult patients with human immunodeficiency virus (HIV) and tubercu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kouanda, Seni, Ouedraogo, Henri Gautier, Cisse, Kadari, Compaoré, Tegwinde Rebeca, Sulis, Giorgia, Diagbouga, Serge, Roggi, Alberto, Tarnagda, Grissoum, Villani, Paola, Sangare, Lassana, Simporé, Jacques, Regazzi, Mario, Matteelli, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318514/
https://www.ncbi.nlm.nih.gov/pubmed/32590942
http://dx.doi.org/10.1186/s12879-020-05169-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318514/
https://www.ncbi.nlm.nih.gov/pubmed/32590942
http://dx.doi.org/10.1186/s12879-020-05169-2

Ejemplares similares